Ibrutinib-associated Pneumocystis jirovecii pneumonia-Reference-Cited by-同舟云学术

Ibrutinib-associated Pneumocystis jirovecii pneumonia

Published:2017-09-28 Issue:11 Volume:92 Page:E646-E648
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Lee Regina¹^ORCID,Nayernama Afrouz¹,Jones S. Christopher¹,Wroblewski Tanya²,Waldron Peter E.¹

Affiliation:

1. Division of Pharmacovigilance; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Silver Spring Maryland

2. Division of Hematology Products; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration; Silver Spring Maryland

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24890/fullpdf

Reference6 articles.

1. Pneumocystis pneumonia;Thomas;N Engl J Med.,2004

2. Clinical picture of Pneumocystis jirovecii pneumonia in cancer patients;Bollée;Chest.,2007

3. ECIL guidelines for the treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients;Maschmeyer;J Antimicrob Chemother.,2016

4. Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib;Ahn;Blood.,2016

5. Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK;Sagiv-Barfi;Proc Natl Acad Sci U S A.,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents;Cancers;2024-05-24

2. Post-transplant GVHD in the era of molecularly targeted therapy;Japanese Journal of Transplantation and Cellular Therapy;2022

3. Pneumocystis jirovecii pneumonia in newly diagnosed treatment-naïve chronic lymphocytic leukaemia;BMJ Case Reports;2021-06

4. A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre‐ibrutinib era;European Journal of Haematology;2020-12-03

5. BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia;Frontiers in Immunology;2020-08-28